Apogee Therapeutics, Inc. (APGE)
134.81
+0.06
(+0.04%)
USD |
NASDAQ |
Aug 24, 16:00
134.81
0.00 (0.00%)
After-Hours: 19:17
Apogee Therapeutics Total Liabilities (Quarterly) : 141.21M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 141.21M |
| March 31, 2026 | 37.86M |
| December 31, 2025 | 33.25M |
| September 30, 2025 | 39.82M |
| June 30, 2025 | 38.37M |
| March 31, 2025 | 40.80M |
| December 31, 2024 | 37.16M |
| September 30, 2024 | 41.88M |
| Date | Value |
|---|---|
| June 30, 2024 | 27.02M |
| March 31, 2024 | 22.18M |
| December 31, 2023 | 21.49M |
| September 30, 2023 | 17.18M |
| June 30, 2023 | 17.62M |
| March 31, 2023 | 11.19M |
| December 31, 2022 | 9.98M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Cogent Biosciences, Inc. | 302.16M |
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
| Intellia Therapeutics, Inc. | 129.46M |
| Revolution Medicines, Inc. | 1.717B |
| Erasca, Inc. | 73.18M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.336B |
| Shareholders Equity (Quarterly) | 1.195B |
| Debt to Equity Ratio | 0.0888 |
| Current Ratio | 26.44 |
| Net Debt Paydown Yield | -0.19% |